ANI Pharmaceuticals, Inc. (ANIP)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$78.91
-0.87%
Mkt Cap $1.79B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 27, 2026 | $231.09M | $247.06M | +6.91% | $1.99 | $2.33 | +17.09% | — | — |
| Q4 2025 Nov 7, 2025 | $232.25M | $227.81M | -1.91% | $1.74 | $2.04 | +17.24% | — | — |
| Q3 2025 Aug 8, 2025 | $208.81M | $211.37M | +1.23% | $1.38 | $1.80 | +30.43% | — | — |
| Q2 2025 May 9, 2025 | $188.73M | $197.12M | +4.44% | $1.37 | $1.70 | +24.09% | — | — |
| Q1 2025 Feb 28, 2025 | $169.96M | $190.57M | +12.13% | $1.41 | $1.63 | +15.60% | — | — |
| Q4 2024 Nov 8, 2024 | $175.12M | $148.33M | -15.30% | $1.09 | $1.34 | +22.94% | — | — |
| Q3 2024 Aug 6, 2024 | $129.05M | $138.04M | +6.97% | $0.93 | $1.02 | +9.68% | — | — |
| Q2 2024 May 10, 2024 | $125.52M | $137.43M | +9.49% | $0.98 | $1.21 | +23.47% | — | — |
| Q1 2024 Feb 29, 2024 | $122.21M | $131.65M | +7.73% | $0.80 | $1.00 | +25.00% | — | — |
| Q4 2023 Nov 8, 2023 | $122.25M | $131.83M | +7.84% | $0.76 | $1.27 | +67.11% | — | — |
| Q3 2023 Aug 9, 2023 | $98.70M | $116.55M | +18.08% | $0.64 | $1.28 | +100.00% | — | — |
| Q2 2023 May 8, 2023 | $83.49M | $106.79M | +27.90% | $0.34 | $1.17 | +244.12% | — | — |
| Q1 2023 Mar 9, 2023 | $86.14M | $94.23M | +9.39% | $0.68 | $0.76 | +11.76% | — | — |
| Q4 2022 Nov 9, 2022 | $78.36M | $83.82M | +6.97% | $0.58 | $0.64 | +10.34% | — | — |
| Q3 2022 Aug 8, 2022 | $71.97M | $73.86M | +2.62% | $0.12 | $0.13 | +8.33% | — | — |
| Q2 2022 May 10, 2022 | $65.03M | $64.48M | -0.86% | $0.08 | -$0.12 | -250.00% | — | — |
| Q1 2022 Mar 15, 2022 | $56.30M | $60.93M | +8.22% | $0.82 | $0.54 | -34.15% | — | — |
| Q4 2021 Nov 1, 2021 | $49.70M | $52.06M | +4.75% | $0.71 | $1.01 | +42.25% | — | — |
| Q3 2021 Aug 6, 2021 | $48.05M | $48.63M | +1.20% | $0.65 | $0.67 | +3.08% | — | — |
| Q2 2021 May 7, 2021 | $48.15M | $54.52M | +13.24% | $0.73 | $1.04 | +42.47% | — | — |